- First-quarter revenue grew organically by 19.1% - Adjusted EBITDA up organically by 10.6% - Gerresheimer raises revenue guidance to double-digit growth for 2022 DÜSSELDORF
Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, is further accelerating its profitable growth. The strategic program